IP
GILD icon

Integras Partners’s Gilead Sciences GILD Stock Holding History

Integras Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.43M Sell
24,623
-1,484
-6% -$208K 2.25% 14
2025
Q4 		$3.2M Sell
26,107
-1,197
-4% -$145K 2.59% 12
2025
Q3 		$3.03M Buy
27,304
+950
+4% +$108K 2.45% 20
2025
Q2 		$2.92M Sell
26,354
-159
-0.6% -$16.9K 2.94% 10
2025
Q1 		$2.97M Sell
26,513
-4,532
-15% -$468K 2.68% 10
2024
Q4 		$2.87M Buy
+31,045
New +$2.8M 2.45% 11

Other funds holding GILD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Integras Partners's GILD Position: Q1 2026 in Review

Integras Partners reduced its Gilead Sciences (GILD) stake by 5.7% in Q1 2026, selling an estimated $208K and leaving 24,623 shares worth $3.43M. The position accounts for 2.25% of the portfolio, ranked #14.

Integras Partners first reported a position in GILD in Q4 2024 and has held it in 6 quarters since. 2,309 funds tracked by Wall St. Rank hold GILD as of Q1 2026.

  • Integras Partners held 24,623 shares of Gilead Sciences worth $3.43M as of Q1 2026.
  • Integras Partners sold 1,484 Gilead Sciences shares in Q1 2026, an estimated $208K.
  • Gilead Sciences made up 2.25% of Integras Partners's portfolio in Q1 2026, its #14 holding.
  • Integras Partners first reported a position in Gilead Sciences in Q4 2024 and has held it in 6 quarters since.
  • 2,309 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2026.

Based on Integras Partners's 13F filing for Q1 2026, filed 12 May 2026.